The MET receptor, also known as the hepatocyte growth factor receptor (HGFR), is a protein that plays a key role in cell proliferation, survival, and migration, particularly in processes such as tissue regeneration and wound healing. Dysregulation of the MET receptor has been linked to various cancers, including lung, breast, and liver cancer, making it a significant focus of research in cancer biology. Studies on the MET receptor aim to understand its signaling pathways, interactions with other proteins, and potential therapeutic strategies for targeting the receptor in cancer treatment. Researchers are also investigating the role of the MET receptor in other diseases and conditions, such as fibrosis and autoimmune disorders. Overall, research on the MET receptor is important for advancing our knowledge of cell signaling and its implications for health and disease.